Concurrent chemoradiotherapy for clinical stage T2 bladder cancer: Report of a single institution

Urology

Volumn 63, Issue 1, 2004, Pages 73-77

  Peyromaure, Michaël ^a   Slama, Jerôme ^b   Beuzeboc, Philippe ^b   Ponvert, Dominique ^b   Debré, Bernard ^b   Zerbib, Marc ^b  

^a Hôpital Cochin ^*  (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CARBOPLATIN; CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; BLADDER CANCER; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CARCINOMA IN SITU; CAUSE OF DEATH; CAVA VEIN DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYSTECTOMY; DIARRHEA; FEMALE; FOLLOW UP; HUMAN; INTESTINE OBSTRUCTION; LUNG EMBOLISM; MALE; METASTASIS; NAUSEA; NEPHROTOXICITY; PRIORITY JOURNAL; PROCTITIS; RADIATION DOSE; TOXICITY; TRANSURETHRAL RESECTION; TUMOR BIOPSY; URETHRA STENOSIS; URINARY TRACT DISEASE; URINARY TRACT FISTULA; URINE RETENTION; VEIN THROMBOSIS; WOUND DEHISCENCE;

EID: 0742306939     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urology.2003.09.018     Document Type: Article

References (19)

1. Stein J.P., Lieskovsky G., Cote R., et al. Radical cystectomy in the treatment of invasive bladder cancer long-term results in 1,054 patients . J Clin Oncol. 19:2001;666-675.
2. Chang S.S., Cookson M.S., Baumgartner R.G., et al. Analysis of early complications after radical cystectomy results of a collaborative care pathway . J Urol. 167:2002;2012-2016.
3. Soulie M., Seguin P., Mouly P., et al. Assessment of morbidity and functional results in bladder replacement with Hautmann ileal neobladder after radical cystectomy a clinical experience in 55 highly selected patients . Urology. 58:2001;707-711.
4. Housset M., Maulard C., Chretien Y.C., et al. Combined radiation and chemotherapy for invasive transitional cell carcinoma of the bladder a prospective study . J Clin Oncol. 11:1993;2150-2157.
5. Chauvet B., Brewer Y., Felix-Faure C., et al. Concurrent cisplatin and radiotherapy for patients with muscle invasive bladder cancer who are not candidates for radical cystectomy. J Urol. 156:1996;1258-1262.
6. Fellin G., Graffer U., Bolner A., et al. Combined chemotherapy and radiation with selective organ preservation for muscle-invasive bladder carcinoma a single-institution phase II study . Br J Urol. 80:1997;44-49.
7. Varveris H., Delakas D., Anezinis P., et al. Concurrent platinum and docetaxel chemotherapy and external radiotherapy in patients with invasive transitional cell bladder carcinoma a preliminary report of tolerance and local control . Anticancer Res. 17:1997;4771-4780.
8. Arias F., Dominguez M.A., Martinez E., et al. Chemoradiotherapy for muscle invading bladder carcinoma final report of a single institutional organ-sparing program . Int J Radiat Oncol Biol Phys. 47:2000;373-378.
9. Rodel C., Grabenbauer G.G., Kuhn R., et al. Combined-modality treatment and selective organ preservation in invasive bladder cancer long-term results . J Clin Oncol. 20:2002;3048-3050.
10. Shipley W.U., Kaufman D.S., Zehr E., et al. Selective bladder preservation by combined modality protocol treatment long-term outcomes of 190 patients with invasive bladder cancer . Urology. 60:2002;62-68.
11. Montie J.E. Editorial comment selective bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer . Urology. 60:2002;67.
12. Brauers A., Buettner R., Jakse G. Second resection and prognosis of primary high risk superficial bladder cancer is cystectomy often too early? J Urol. 165:2001;808-810.
13. Herr H.W. The value of second transurethral resection in evaluating patients with bladder tumors. J Urol. 162:1999;74-76.
14. Lance R.S., Grossman H.B. Cystectomy in the elderly. Semin Urol Oncol. 19:2001;51-55.
15. Scholten A.N., Leer J.W., Collins C.D., et al. Hypofractionated radiotherapy for invasive bladder cancer. Radiother Oncol. 43:1997;163-169.
16. Moonen L.M., van der Voet H., De Nijs R., et al. Muscle-invasive bladder cancer treated with external beam radiotherapy pretreatment prognostic factors and the predictive value of cystoscopic re-evaluation during treatment . Radiother Oncol. 49:1998;149-155.
17. Herr H.W. Transurethral resection of muscle-invading bladder cancer ten-year outcome . J Clin Oncol. 19:2001;89-93.
18. de la Rosa F., Garcia-Carbonero R., Passas J., et al. Primary cisplatin, methotrexate and vinblastine chemotherapy with selective bladder preservation for muscle invasive carcinoma of the bladder long-term followup of a prospective study . J Urol. 167:2002;2413-2418.
19. Vallancien G., Abou El Fettouh H., Cathelineau X., et al. Cystectomy with prostate sparing for bladder cancer in 100 patients 10-year experience . J Urol. 168:2002;2413-2417.